GlobeNewswire Inc. · Feb 1, 2024
VIVEON HEALTHCARE ACQUISITION CORP CONFIRMS BUSINESS COMBINATION
Viveon combination with Clearday continues to move forward
VH
AMEX · VHAQ
Viveon Health Acquisition Corp.
Financial Services · Shell Companies
$10.00
Up+$0.00 (+0.00%)
Updated Aug 23, 2026, 9:14 PM
SID Score
—
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 66.49M
- P/E ratio
- -251.12
- Dividend yield
- 0.00%
- 52-week range
- — – —
- Volume
- 1
- Avg. volume
- 38
Price performance
VHAQ price history
1M range · 0 trading sessions · Daily adjusted prices
VHAQ does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
Latest VHAQ news
The latest Smart Investors Daily articles mentioning VHAQ.
Stock researchCompany · Overview
VHAQ research
Overview
Company profile and research snapshot.
Company profile
Viveon Health Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses in the healthcare industry in North America. The company was incorporated in 2020 and is based in Norcross, Georgia.
Analyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
News briefing
No generated briefing is available yet.
GlobeNewswire Inc. · Dec 27, 2023
Viveon Health Acquisition Corp. Receives Commencement of Delisting Notice From the NYSE
Atlanta, GA, Dec. 27, 2023 (GLOBE NEWSWIRE) -- Viveon Health Acquisition Corp. (NYSE: VHAQ, VHAQW, VHAQR, VHAQU the “Company”) announces that, as previously disclosed in the Current Report on Form 8-K filed on December 26, 2023 with the United States Securities and Exchange Commission, the Company received a letter from the NYSE American LLC (“NYSE American” or the “Exchange”) on December 22, 2023, stating that the staff of NYSE Regulation has determined to commence proceedings to delist the Company’s Common Stock, Units and Rights (collectively, the “Securities”) pursuant to Sections 119(b) and 119(f) of the NYSE American Company Guide because the Company failed to consummate a business combination within 36 months of the effectiveness of its initial public offering registration statement, or such shorter period that the Company specified in its registration statement.
GlobeNewswire Inc. · Sep 15, 2023
VIVEON HEALTH ACQUISITION CORP. RECEIVED AUDIT OPINION WITH GOING CONCERN EXPLANATION
ATLANTA, GEORGIA, Sept. 15, 2023 (GLOBE NEWSWIRE) -- Viveon Health Acquisition Corp. (Viveon Health Acquisition Corp. (NYSE American: VHAQ, VHAQW, VHAQR, VHAQU) (“Viveon” or the “Company”) announced today that, as previously disclosed in its annual report on Form 10-K for the fiscal year ended December 31, 2022, which was filed on August 24, 2023 with the U.S. Securities and Exchange Commission, the audited financial statements contained an audit opinion from its independent registered public accounting firm that included an explanatory paragraph related to the Company's ability to continue as a going concern. See further discussion in Note 1 to the Company's financial statements included in the Company's Annual Report on Form 10-K for the year ended December 31, 2022. This announcement is made pursuant to NYSE American LLC Company Guide Sections 401(h) and 610(b), which require public announcement of the receipt of an audit opinion containing a going concern paragraph. This announcement does not represent any change or amendment to the Company's financial statements or to its Annual Report on Form 10-K for the year ended December 31, 2022.
GlobeNewswire Inc. · Aug 29, 2023
Viveon Health Acquisition Corp. and Clearday, Inc. Announce Amendment to their Definitive Merger Agreement
Norcross GA and San Antonio, TX, Aug. 29, 2023 (GLOBE NEWSWIRE) -- Viveon Health Acquisition Corp. (NYSE American: VHAQ) (“Viveon”), a special purpose acquisition company, and Clearday, Inc. (CLRD) (“Clearday”), an innovative longevity technology company using an integrated platform of robotic companion care and AI-driven technology to serve the senior adult care sector, announced today that they have amended the terms of their previously announced Merger Agreement, dated as of April 5, 2023 (the “Merger Agreement”). Pursuant to the terms of the Merger Agreement, a business combination between Viveon and Clearday will be effected through the merger of a wholly owned subsidiary of Viveon with and into Clearday, with Clearday surviving the merger as a wholly owned subsidiary of Viveon (the “Merger”).
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
